Background: Chronically ill adults insured by Medicaid experience health inequities following hospitalisation.

Local Problem: Postacute outcomes, including rates of 30-day readmissions and postacute emergency department (ED), were higher among Medicaid-insured individuals compared with commercially insured individuals and social needs were inconsistently addressed.

Methods: An interdisciplinary team introduced a clinical pathway called 'THRIVE' to provide postacute wrap-around services for individuals insured by Medicaid.

Intervention: Enrolment into the THRIVE clinical pathway occurred during hospitalisation and multidisciplinary services were deployed into homes within 48 hours of discharge to address clinical and social needs.

Results: Compared with those not enrolled in THRIVE (n=437), individuals who participated in the THRIVE clinical pathway (n=42) experienced fewer readmissions (14.3% vs 28.4%) and ED visits (14.3% vs 28.8 %).

Conclusion: THRIVE is a promising clinical pathway that increases access to ambulatory care after discharge and may reduce readmissions and ED visits.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9345087PMC
http://dx.doi.org/10.1136/bmjoq-2021-001798DOI Listing

Publication Analysis

Top Keywords

clinical pathway
16
medicaid-insured individuals
8
thrive clinical
8
individuals
5
clinical
5
transitional care
4
care innovation
4
innovation medicaid-insured
4
individuals early
4
early findings
4

Similar Publications

Dysregulated lipid metabolism within the tumor microenvironment (TME) is a critical hallmark of cancer progression, with lipids serving as a major energy source for tumor cells. Beyond their role in cell membrane synthesis, lipids also provide essential substrates for biomolecule production and activate signaling pathways that regulate various cellular processes. Aberrant lipid metabolism impacts not only function but also alters the behavior of immune and stromal cells within the TME.

View Article and Find Full Text PDF

Lung cancer is correlated with a high death rate, with approximately 1.8 million mortality cases reported worldwide in 2022. Despite development in the control of lung cancer, most cases are detected at higher stages with short survival rates.

View Article and Find Full Text PDF

Decoding Epilepsy: Prickle2 and Multifaceted Molecular Pathway Connections.

Curr Pharm Des

January 2025

Hubei Key Laboratory of Tumor Microenvironment and Immunotherapy, China Three Gorges University, Yichang, Hubei, China.

Background: The Prickle2 (Pk2) gene shows promising potential in uncovering the underlying causes of epilepsy, a neurological disorder that is currently not well understood. This paper utilizes the online tool PubMed to gather and condense information on the involvement of PCP channels and the associated roles of PCP pathway molecules in the onset of epilepsy. These findings are significant for advancing epilepsy treatment.

View Article and Find Full Text PDF

Understanding Tankyrase Inhibitors and Their Role in the Management of Different Cancer.

Curr Cancer Drug Targets

January 2025

Department of Pharmaceutical Chemistry, JSS College of Pharmacy, JSS Academy of Higher Education & Research, Ooty, Nilgiris, Tamil Nadu, India.

Cancer manifests as uncontrolled cell proliferation. Tankyrase, a poly(ADP-ribose) polymerase member, is vital in Wnt signal transmission, making it a promising cancer therapy target. The Wnt/β-catenin pathway regulates critical biological processes like genomic stability, gene expression, energy utilization, and apoptosis.

View Article and Find Full Text PDF

Atomically Dispersed Metal-Nitrogen-Carbon Catalysts for Acidic Oxygen Reduction Reaction.

ACS Appl Mater Interfaces

January 2025

School of Integrated Circuits, Wuhan National Laboratory for Optoelectronics, Huazhong University of Science and Technology, Wuhan 430074, P. R. China.

Designing efficient and cost-effective electrocatalysts toward oxygen reduction reaction (ORR) under demanding acidic environments plays a critical role in advancing proton exchange membrane fuel cells (PEMFCs). Metal-nitrogen-carbon (M-N-C) catalysts with atomically dispersed metals have gained attention for their affordability, excellent catalytic performance, and distinctive features including consistent active sites and high atomic utilization. Over the past decade, significant achievements have been made in this field.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!